vs
Castellum, Inc.（CTM）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
ROCKWELL MEDICAL, INC.的季度营收约是Castellum, Inc.的1.5倍（$18.3M vs $12.6M），ROCKWELL MEDICAL, INC.净利率更高（-3.0% vs -10.5%，领先7.5%），Castellum, Inc.同比增速更快（21.9% vs -25.6%），过去两年Castellum, Inc.的营收复合增速更高（5.3% vs -10.1%）
Castellum, Inc.是一家总部位于美国的网络安全与信息技术服务提供商，服务覆盖国防政府机构、公共部门及商业企业客户，提供威胁检测、数据保护、云安全及托管IT解决方案，助力客户防范网络风险、保护核心数字资产。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
CTM vs RMTI — 直观对比
营收规模更大
RMTI
是对方的1.5倍
$12.6M
营收增速更快
CTM
高出47.6%
-25.6%
净利率更高
RMTI
高出7.5%
-10.5%
两年增速更快
CTM
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.6M | $18.3M |
| 净利润 | $-1.3M | $-554.0K |
| 毛利率 | 33.9% | 21.1% |
| 营业利润率 | -11.1% | -2.2% |
| 净利率 | -10.5% | -3.0% |
| 营收同比 | 21.9% | -25.6% |
| 净利润同比 | 51.8% | 26.7% |
| 每股收益（稀释后） | $-0.02 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTMRMTI
| Q4 25 | $12.6M | $18.3M | ||
| Q3 25 | $14.6M | $15.9M | ||
| Q2 25 | $14.0M | $16.1M | ||
| Q1 25 | $11.7M | $18.9M | ||
| Q4 24 | $10.3M | $24.7M | ||
| Q3 24 | $11.6M | $28.3M | ||
| Q2 24 | $11.5M | $25.8M | ||
| Q1 24 | $11.3M | $22.7M |
净利润CTMRMTI
| Q4 25 | $-1.3M | $-554.0K | ||
| Q3 25 | $415.4K | $-1.8M | ||
| Q2 25 | $-322.1K | $-1.5M | ||
| Q1 25 | $-1.2M | $-1.5M | ||
| Q4 24 | $-2.7M | $-756.0K | ||
| Q3 24 | $-1.3M | $1.7M | ||
| Q2 24 | $-1.8M | $343.0K | ||
| Q1 24 | $-4.1M | $-1.7M |
毛利率CTMRMTI
| Q4 25 | 33.9% | 21.1% | ||
| Q3 25 | 37.6% | 14.3% | ||
| Q2 25 | 36.1% | 15.6% | ||
| Q1 25 | 39.0% | 16.1% | ||
| Q4 24 | 40.0% | 14.7% | ||
| Q3 24 | 42.7% | 22.0% | ||
| Q2 24 | 40.6% | 17.6% | ||
| Q1 24 | 39.8% | 13.5% |
营业利润率CTMRMTI
| Q4 25 | -11.1% | -2.2% | ||
| Q3 25 | 3.0% | -9.9% | ||
| Q2 25 | -2.7% | -8.4% | ||
| Q1 25 | -12.7% | -7.2% | ||
| Q4 24 | -15.7% | -2.1% | ||
| Q3 24 | -11.9% | 6.8% | ||
| Q2 24 | -13.6% | 2.0% | ||
| Q1 24 | -23.6% | -5.8% |
净利率CTMRMTI
| Q4 25 | -10.5% | -3.0% | ||
| Q3 25 | 2.8% | -11.0% | ||
| Q2 25 | -2.3% | -9.3% | ||
| Q1 25 | -10.0% | -8.0% | ||
| Q4 24 | -26.6% | -3.1% | ||
| Q3 24 | -11.0% | 5.9% | ||
| Q2 24 | -16.0% | 1.3% | ||
| Q1 24 | -36.3% | -7.6% |
每股收益（稀释后）CTMRMTI
| Q4 25 | $-0.02 | $-0.01 | ||
| Q3 25 | $0.00 | $-0.05 | ||
| Q2 25 | $0.00 | $-0.05 | ||
| Q1 25 | $-0.01 | $-0.04 | ||
| Q4 24 | $-0.05 | $-0.02 | ||
| Q3 24 | $-0.02 | $0.04 | ||
| Q2 24 | $-0.03 | $0.01 | ||
| Q1 24 | $-0.08 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $10.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $35.8M | $37.0M |
| 总资产 | $41.9M | $57.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTMRMTI
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
总债务CTMRMTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $8.3M | — | ||
| Q2 24 | $8.7M | — | ||
| Q1 24 | $9.0M | — |
股东权益CTMRMTI
| Q4 25 | $35.8M | $37.0M | ||
| Q3 25 | $36.7M | $37.0M | ||
| Q2 25 | $31.8M | $30.4M | ||
| Q1 25 | $26.1M | $31.5M | ||
| Q4 24 | $20.2M | $32.6M | ||
| Q3 24 | $12.0M | $29.1M | ||
| Q2 24 | $12.1M | $23.5M | ||
| Q1 24 | $12.8M | $20.6M |
总资产CTMRMTI
| Q4 25 | $41.9M | $57.1M | ||
| Q3 25 | $46.3M | $57.5M | ||
| Q2 25 | $43.4M | $52.6M | ||
| Q1 25 | $41.1M | $54.0M | ||
| Q4 24 | $37.8M | $59.2M | ||
| Q3 24 | $28.8M | $57.1M | ||
| Q2 24 | $29.5M | $53.0M | ||
| Q1 24 | $30.5M | $50.7M |
负债/权益比CTMRMTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 0.72× | — | ||
| Q1 24 | 0.70× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-661.7K | $2.3M |
| 自由现金流经营现金流 - 资本支出 | — | $2.2M |
| 自由现金流率自由现金流/营收 | — | 12.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.2M |
8季度趋势，按日历期对齐
经营现金流CTMRMTI
| Q4 25 | $-661.7K | $2.3M | ||
| Q3 25 | $1.0M | $-1.3M | ||
| Q2 25 | $214.2K | $1.8M | ||
| Q1 25 | $-2.5M | $-3.5M | ||
| Q4 24 | $-394.4K | $865.0K | ||
| Q3 24 | $742.2K | $4.3M | ||
| Q2 24 | $748.6K | $1.4M | ||
| Q1 24 | $23.7K | $-2.4M |
自由现金流CTMRMTI
| Q4 25 | — | $2.2M | ||
| Q3 25 | $957.0K | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | $738.9K | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
自由现金流率CTMRMTI
| Q4 25 | — | 12.0% | ||
| Q3 25 | 6.5% | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | 6.4% | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
资本支出强度CTMRMTI
| Q4 25 | — | 0.5% | ||
| Q3 25 | 0.3% | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | 0.0% | 1.6% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 0.0% | 0.6% |
现金转化率CTMRMTI
| Q4 25 | — | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTM
暂无分部数据
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
